NEUMORA THERAPEUTICS, INC. (NMRA) Capital expenditures 2023–2024
NEUMORA THERAPEUTICS, INC. (NMRA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$117,000FY2024 · since FY2023: $511,000 → $117,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $117,000 | -77.1% |
| FY2023 | $511,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice